Cargando…
Targeting CDK9: A novel biomarker in the treatment of endometrial cancer
Endometrial cancer is one of the three major malignant tumors of the female reproductive system. Although cyclin-dependent kinase 9 (CDK9) has a definitive pathogenic role in various types of cancer, little is known concerning its function in endometrial cancer. Our study was conducted to evaluate t...
Autores principales: | He, Shasha, Fang, Xiaoling, Xia, Xiaomeng, Hou, Tao, Zhang, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551504/ https://www.ncbi.nlm.nih.gov/pubmed/32901849 http://dx.doi.org/10.3892/or.2020.7746 |
Ejemplares similares
-
Targeting CDK9 for treatment of colorectal cancer
por: Rahaman, Muhammed H., et al.
Publicado: (2019) -
CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021) -
Targeting CDK9 for the Treatment of Glioblastoma
por: Ranjan, Alice, et al.
Publicado: (2021) -
Endometrial epithelial cells-derived exosomes deliver microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell invasion and migration in ovarian endometriosis
por: Zhang, Mengmeng, et al.
Publicado: (2022) -
Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022)